American Oncology Institute - Nallagandla

The American Oncology Institute, established in 2012 and situated in Nallagandla, Hyderabad, is dedicated to delivering exceptional cancer care. As the flagship international center of Cancer Treatment Services International (CTSI) based in the US, its mission is to bridge the gap between healthcare standards in India and the US. They aim to bring the latest advancements in cancer treatment from highly developed countries to the people of India, ensuring that their patients receive healthcare that meets Western standards. This commitment guarantees that all their patients benefit from the most advanced and innovative cancer treatments available globally.

This hospital unit is committed to providing superior care and diverse treatment options within a patient-focused environment. Specialized services span Radiation Oncology, Radiology, Surgical Oncology, Medical Oncology, Head-Neck Surgery, Musculoskeletal Oncology, Hemato-Oncology, Pediatric Oncology, and Neuro-Oncology Surgery. The hospital takes pride in its state-of-the-art infrastructure, offering essential facilities such as well-equipped intensive care units, blood banks, and a cutting-edge laboratory. Technological advancements, including an MRI 1.5 Tesla, Discover 600 PET/CT, True-beam, and Calypso, further enhance its medical capabilities.

Patient satisfaction is a top priority for the American Oncology Institute. The institution emphasizes understanding patients' needs, collaborating closely, and fostering a serene and comfortable therapeutic environment.

Moreover, the American Oncology Institute, Nallagandla, has been honored with several prestigious awards. These include the Best Hospital Chain Award - 2020 and the Frost & Sullivan 2020 Indian Oncology Service Provider Competitive Strategy Innovation and Leadership Award.